What are the treatment options for urinary urgency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment Options for Urinary Urgency

Bladder training should be the first-line treatment for urinary urgency, followed by pharmacologic therapy with mirabegron if bladder training is unsuccessful. 1, 2

First-Line Treatments: Non-Pharmacological Approaches

Behavioral Modifications

  • Bladder training: Strong recommendation with moderate-quality evidence 1
    • Involves scheduled voiding and gradually extending time between voids
    • Shown to significantly reduce urgency episodes

Lifestyle Modifications

  • Weight loss and exercise: Strong recommendation for obese patients 1
  • Fluid management:
    • Moderate fluid restriction, especially in evening hours 2
    • Reducing fluid intake by 25-50% can decrease urgency symptoms 3
  • Avoid bladder irritants: 2, 4
    • Caffeinated, carbonated, and citrus beverages (associated with 37% higher odds of urgency incontinence) 4
    • High-acid foods (associated with 29% higher odds of urgency incontinence) 4
    • Alcohol, spicy foods, chocolate, and artificial sweeteners

Physical Therapy

  • Pelvic floor muscle training (PFMT):
    • Particularly effective for mixed urinary incontinence when combined with bladder training 1
    • Can improve urinary frequency even without incontinence 2

Second-Line Treatments: Pharmacological Approaches

If bladder training is unsuccessful, pharmacologic treatment is recommended (strong recommendation, high-quality evidence) 1.

Recommended Medication Algorithm:

  1. First choice: Mirabegron (β3 agonist) 2, 5

    • FDA-approved for overactive bladder with symptoms of urge incontinence, urgency, and frequency 5
    • Starting dose: 25 mg once daily, may increase to 50 mg after 4-8 weeks if needed 5
    • Preferred for patients with risk factors for urinary retention 2
    • Does not cause antimuscarinic side effects (dry mouth, constipation)
  2. Second choice: Solifenacin or Darifenacin 2

    • Solifenacin achieves continence better than placebo (NNTB: 9) 2
    • Lower discontinuation rates due to adverse effects compared to other antimuscarinics 2
  3. Third choice: Tolterodine 2, 6

    • Achieves continence (NNTB: 12) and improves urinary incontinence (NNTB: 10) better than placebo 2
    • Better side effect profile than oxybutynin, with fewer adverse effects (NNTH: 12) 2
    • Proven effective in multiple randomized controlled trials 6
  4. Last resort: Oxybutynin or Fesoterodine 2

    • Higher rates of adverse effects than placebo (NNTH: 8) 2
    • Oxybutynin has high rates of dry mouth (71.4%), constipation (15.1%), and other side effects 2

Special Considerations

Dosage Adjustments

  • Renal impairment: Reduce mirabegron dose for patients with eGFR <30 mL/min/1.73m² 5
  • Hepatic impairment: Reduce mirabegron dose for moderate hepatic impairment; avoid in severe impairment 5

Managing Side Effects

  • Constipation: Consider switching to an antimuscarinic with lower constipation risk 2
  • Dry mouth: Ensure adequate hydration, sugar-free gum/candy, or consider transdermal formulations 2
  • Cognitive concerns: Consider trospium which has lower blood-brain barrier penetration 2

Men with Urinary Urgency

  • Consider combination therapy with α-blockers if BPH is present 2, 7
  • α-blockers with 5α-reductase inhibitors reduce progression risk to <10% compared to 10-15% with monotherapy 7

Advanced Therapies for Refractory Cases

For patients who fail conservative and pharmacologic treatments:

  • Sacral neuromodulation (SNS) 2
  • Peripheral tibial nerve stimulation (PTNS) 2
  • OnabotulinumtoxinA injections (with counseling about potential self-catheterization) 2
  • Consider referral to urology for surgical options 2

Pitfalls to Avoid

  • Don't overlook potential infectious causes in women with persistent symptoms; consider doxycycline treatment which has shown 71% effectiveness in some studies 8
  • Don't start antimuscarinic therapy without measuring post-void residual volume to minimize urinary retention risk 2
  • Avoid high doses of antimuscarinics in elderly patients due to increased risk of cognitive side effects
  • Don't ignore fluid intake modification as a simple but effective intervention

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Urinary Retention Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Does Increasing or Decreasing the Daily Intake of Water/Fluid by Adults Affect Overactive Bladder Symptoms?

Journal of wound, ostomy, and continence nursing : official publication of The Wound, Ostomy and Continence Nurses Society, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.